Skip to page content

Rob Boer — Publications

Validity of Race, Ethnicity, and National Origin in Population-Based Cancer Registries and Rapid Case Ascertainment Enhanced with a Spanish Surname List

2013
Estimating the Global Health Impact of Improved Diagnostic Tools for the Developing World

2007
How Neighborhoods Can Reduce the Risk of Obesity

2007
Human Papillomavirus Triage of Women with Persistent Borderline or Mildly Dyskaryotic Smears: Comparison of Costs and Side Effects of Three Alternative Strategies

2007
Neighborhood Design and Walking Trips in Ten U.S. Metropolitan Areas

2007
Chapter 13: A Comparative Review of CISNET Breast Models Used to Analyze U.S. Breast Cancer Incidence and Mortality Trends

2006
Determining the Priority Global Health Needs and Quantifying the Health Benefits Resulting From the Introduction of New Diagnostics in the Developing World

2006
Developing and Interpreting Models to Improve Diagnostics in Developing Countries

2006
How Much Can Current Interventions Reduce Colorectal Cancer Mortality in the U.S.? Mortality Projections for Scenarios of Risk-Factor Modification, Screening, and Treatment

2006
The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer

2006
Reducing the Global Burden of Acute Lower Respiratory Infections in Children: The Contribution of New Diagnostics

2006
Seventy-five Years Is an Appropriate Upper Age Limit for Population-Based Mammography Screening

2006
A Technical Supplement: Reducing the Global Burden of Acute Lower Respiratory Infections in Children: The Contribution of Improved Diagnostics

2006
Transmission Patterns of Smallpox: Systematic Review of Natural Outbreaks in Europe and North America Since World War II

2006
Will Smallpox Vaccinations Save Lives?

2005
Developing and Comparing Population Models for the Early Detection of Cancer

2004
Diversity of Model Approaches for Breast Cancer Screening: A Review of Model Assumptions by the Cancer Intervention Surveillance Network (CISNET) Breast Cancer Groups

2004
Mammography Benefit in the Canadian National Breast Screening Study-2: A Model Evaluation

2004
National Polyp Study Data: Evidence for Regression of Adenomas

2004
Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates from the European Randomized Study of Screening for Prostate Cancer

2003
A Model for a Smallpox-Vaccination Policy

2003
Cost-effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

2002
Impact of Systematic False-Negative Test Results on the Performance of Faecal Occult Blood Screening

2001
Important Influences on Effectiveness and Costs to Be Considered in the Evaluation of Cancer Screening

2001
Pathologic Features of Prostate Cancer Found at Population-Based Screening with a Four-Year Interval

2001
Endoscopic Colorectal Cancer Screening: A Cost-Saving Analysis

2000
Investigation of Design and Bias Issues in Case-Control Studies of Cancer Screening Using Microsimulation

2000
Re: Improving the Cost-Effectiveness of Colorectal Cancer Screening

2000
A Longer Breast Carcinoma Screening Interval for Women Age Older Than 65 Years?

1999
Quebec Randomized Controlled Trial on Prostate Cancer Screening Shows No Evidence for Mortality Reduction

1999
Stage Distribution at First and Repeat Examinations in Breast Cancer Screening

1999
Cost Effectiveness of Shortening Screening Interval or Extending Age Range of NHS Breast Screening Programme: Computer Simulation Study

1998